By inhibiting the transcriptional activity of β-catenin, berberine modulates the Wnt signaling pathway [31] and increases the expression of caspase-3 and -8; thus, it promotes apoptosis of ovarian cancer cells, when used in combination with cisplatin [32]. Here, CASP3 is linked to ovarian cancer.